Health & Environment
Aurobindo Pharma Secures US FDA Approval for Generic Asthma Inhaler
The Hindu22h
THE BRIEF
1
Aurobindo Pharma received final U.S. FDA approval to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths.
2
The product serves as a generic equivalent to Teva's QVAR Inhalation Aerosol and marks Aurobindo's entry into complex respiratory treatments.
3
The drug will be produced at subsidiary Aurolife Pharma's facility in North Carolina, targeting a U.S. market estimated at $301 million.